« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1360-1362
, December 2009
Increased IFN-γ activity in seasonal allergic rhinitis is decreased by corticosteroid treatment
References
- Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science. 1995;269:245–247
- . T-cell responses to allergens. J Allergy Clin Immunol. 2007;119:280–294
- . Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol. 2000;106:307–312
- . A network-based analysis of the late-phase reaction of the skin. J Allergy Clin Immunol. 2006;118:220–225
- . Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8 + T cells in atopic asthma. Am J Respir Crit Care Med. 2005;171:224–230
- . Interferon gamma enhances both in vitro and in vivo priming of CD41 T cells for IL-4 production. J Exp Med. 2004;199:1619–1630
- . Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med. 2004;199:535–545
- Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity. 2006;25:237–247
- Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps. J Allergy Clin Immunol. 2004;113:1137–1143
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01438-9
doi: 10.1016/j.jaci.2009.09.037
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1360-1362
, December 2009
